Cargando…

Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint

Since COVID-19 has emerged as a word public health problem, attention has been focused on how immune-suppressive drugs used for the treatment of autoimmune disorders influence the risk for SARS-CoV-2 infection and the development of acute respiratory distress syndrome (ARDS). Here, we discuss the di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alborghetti, Marika, Bellucci, Gianmarco, Gentile, Antonietta, Calderoni, Chiara, Nicoletti, Ferdinando, Capra, Ruggero, Salvetti, Marco, Centonze, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199540/ https://www.ncbi.nlm.nih.gov/pubmed/33784961 http://dx.doi.org/10.2174/1570159X19666210330094017

Ejemplares similares

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022)

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
por: Marfia, Girolama Alessandra, et al.
Publicado: (2022)

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2022)

Genome-Wide Multiple Sclerosis Association Data and Coagulation
por: La Starza, Sara, et al.
Publicado: (2019)

A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
por: Buscarinu, Maria Chiara, et al.
Publicado: (2022)

Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
por: Bianchini, Edoardo, et al.
Publicado: (2022)

Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
por: Alborghetti, Marika, et al.
Publicado: (2019)

Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis
por: Nisticò, Robert, et al.
Publicado: (2013)

Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis
por: Ziccardi, Lucia, et al.
Publicado: (2020)

Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey
por: Carbone, Luigi, et al.
Publicado: (2023)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Predictors of Evolution Into Multiple Sclerosis After a First Acute Demyelinating Syndrome in Children and Adolescents
por: Papetti, Laura, et al.
Publicado: (2019)

The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
por: Bellucci, Gianmarco, et al.
Publicado: (2023)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)

Noise in multiple sclerosis: unwanted and necessary
por: Bordi, Isabella, et al.
Publicado: (2014)

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

Macrophage Plasticity and Polarization Are Altered in the Experimental Model of Multiple Sclerosis
por: Leuti, Alessandro, et al.
Publicado: (2021)

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany
por: Solari, Alessandra, et al.
Publicado: (2019)

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
por: Romano, Silvia, et al.
Publicado: (2019)

Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis
por: Cennamo, Gilda, et al.
Publicado: (2020)

MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease
por: Cortese, Rosa, et al.
Publicado: (2021)

A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
por: Angeloni, Benedetta, et al.
Publicado: (2021)

Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2015)

Determinants of early working impairments in multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2022)

Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis
por: Giorgio, Antonio, et al.
Publicado: (2020)

Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
por: Umeton, Renato, et al.
Publicado: (2022)

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology
por: Mancinelli, Chiara Rosa, et al.
Publicado: (2021)

Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson’s Disease: Beyond the Primary Mechanism of Action
por: Rinaldi, Domiziana, et al.
Publicado: (2023)

Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus
por: Filippi, Massimo, et al.
Publicado: (2021)

Brain Volume and Perception of Cognitive Impairment in People With Multiple Sclerosis and Their Caregivers
por: Fenu, Giuseppe, et al.
Publicado: (2021)

Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements
por: Lorefice, Lorena, et al.
Publicado: (2023)

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2019)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

Ten Rules for the Management of Moderate and Severe Traumatic Brain Injury During Pregnancy: An Expert Viewpoint
por: Di Filippo, Simone, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tl89sg8ub24uvd83ov9g33khr8